Adrenergic Drugs I Flashcards

1
Q

adrenergic receptors are _

A

GPCR’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

alpha-1 receptors

A

Gq phosphorylates alpha subunit –> beta-gamma detach –> Galpha-Pi activates PLC –> PLC cleaves PIP2 into DAG and IP3 (2nd messengers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

alpha-1 receptor functions

A

vasoconstriction, smooth muscle relaxation, contraction of GI tract, increase heart force, and stimulates glygenolysis/gluconeogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

muscle contraction by alpha-1 receptors

A

increases intracellular [Ca++] via release of intracellular stores –> calmodulin activation –> phosphorylation of MLCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

alpha-2 receptors

A

activation of Gi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Gi protein

A

inhibits adenylyl cyclase, reducing cAMP; also activates K+ channels for repolarization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

alpha-2 receptor functions

A

contraction of smooth muscle, decreases insulin secretion, decreases NE release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

beta-receptors

A

activate Gs which activates adenylyl cyclase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

beta-1 receptors

A

in heart, kidneys, and adipocytes; produce positive inotropic and chronotropic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

beta-2 receptors

A

in heart, vascular, bronchial and GI smooth muscle, glands, leukocytes, hepatocytes; smooth muscle relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

beta-3 receptors

A

in adipose tissue and GI tract; metabolic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

beta receptors are found on _

A

post-synaptic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

alpha-2 receptors are found on _

A

pre or post-synaptic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

alpha-1 receptors are found on _

A

post-synaptic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

beta-1 effects

A

tachycardia, increased renin, increased myocardial contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

beta-2 effects

A

vasodilation, decreased peripheral resistance, bronchodilation, increases glucagon, increases glycogenolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

signal termination steps

A

desensitization –> sequestration –> recycling/degradation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

desensitization

A

ligand binding promotes phosphorylation of receptor –> beta-arrestin will bind –> now less sensitive to hormones or NTs binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

sequestration

A

after beta-arrestin binds, clathrin-coated vesicles will form –> pulls receptor away from membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

catecholamines

A

dopamine, norepinephrine, epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

high dose epinephrine

A

increase vasoconstriction, increase inotropy, increase chonotropy, increase HR and BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

low dose epinephrine

A

vasodilation, increase inotropy and chonotropy so still increases HR and CO (increased to overcome vasodilation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

at low doses epinephrine will bind _

A

beta receptors which allows vasodilation

24
Q

at high doses epinephrine binds _

A

alpha receptors which causes vasoconstriction (lower affinity for alpha than beta)

25
epinephrine smooth muscle effects
relaxes GI smooth muscle (alpha and beta) and contracts bladder sphincter (alpha only)
26
epinephrine respiratory effects
relaxes bronchial smooth muscle
27
epinephrine metabolic effects
elevates blood glucose (decreases insulin secretion) and increases metabolism (increases triglyceride lipase activity and FFA)
28
epinephrine therapeutic uses
treatment of bronchospasm, relief of hypersensitivity reactions, prolong local anesthetics, topical hemostatic agent
29
low doses of dopamine
binds dopamine receptors and causes vasodilation and Na+ reabsorption
30
high doses of dopamine
binds beta-1 receptors causing inotropic effects, induces release of NE
31
very high doses of epinephrine
binds vascular alpha-1 receptors and causes vasoconstriction
32
life cycle of NTs
1. synthesis 2. uptake into storage vesicles 3. release 4. receptor binding 5. removal/reuptake 6. metabolism
33
synthesis of catecholamines
tyrosine --> L-DOPA --> dopamine --> norepinephrine or epinephrine
34
rate limiting step in catecholamine synthesis
tyrosine hydroxylase hydroxylating tyrosine
35
uptake into storage vesicles
dopamine enters a vesicle and is converted to NE or E; protected from degradation in vesicle (presynaptic cell)
36
VMAT1 and VMAT2
transport catecholamines into storage vesicles
37
VMAT1
peripheral
38
VMAT2
CNS
39
reserpine
irreversibly binds VMAT and inhibits them from taking up catecholamines; will deplete the storage vesicles
40
therapeutic uses of reserpine
antihypertensive; not used because of CNS effects
41
catecholamine release
influx of calcium (from AP) causes fusion of the vesicles with the cell membrane through exocytosis
42
catecholamine reuptake
norepinephrine transporter (NET) transports back into neuron
43
reuptake inhibiters
SNRIs, cocaine, imipramine
44
imipramine
tricyclic antidepressant; block NET and prolong stimulation of receptors
45
cocaine
blocks NET and DAT; prolongs stimulation of both central and peripheral receptors; can be used as local anesthetic
46
catecholamine metabolism
done by monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT)
47
MAO-A
noradrenergic neurons
48
MAO-B
serotonergic and histaminergic neurons
49
COMT
not found in sympathetic neurons
50
MAO-A inhibition
responsible for antidepressant effects
51
MAO-B inhibition
decreases dopamine metabolism in the brain; useful for Parkinson's
52
safinamide
MAO-B inhibitor; Parkinson's disease
53
isocarboxazid & seleginline
MAO inhibitors
54
tolcapone & entacapone
COMT inhibitors; Parkinson's disease (with levodopa)
55
COMT inhibitors
inhibit levodopa metabolism, leaving more available for conversion to dopamine